Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Riddell PhD

Michael C. Riddell PhD

Professor, School of Kinesiology and Health Science, Muscle Health Research Center, York University; Senior Scientist, LMC Diabetes and Centricity Research, Toronto, Ontario, Canada

Michael C. Riddell is a Professor in the School of Kinesiology and Health Science and Muscle Health Research Center at York University in Toronto. He is also a Senior Scientist at LMC Diabetes and Centricity Research in Toronto where he leads clinical studies on glucose management strategies for exercise in type 1 diabetes. Dr. Riddell enjoys running and cycling while attempting to manage his own type 1 diabetes with a hybrid closed-loop insulin pump.


Dr. Riddell serves on advisory boards for Eli Lilly, Indigo, Insulet, Supersapiens, and Zucara Therapeutics and has given industry-supported lectures for Eli Lilly, Insulet, Novo Nordisk, and Sanofi. No other potential conflicts of interest were reported.